*Result*: Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2021
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Trials. - 22, 1 (2021) , 543, ISSN: 1745-6215
*DOI*:
10.1186/s13063-021-05520-1